Archive for December 20th, 2011

SNTS files NDA. ZGNX NDA due 2Q 2012 + PGNX Phase 3 data.

Dec 20, 2011 No Comments by

Santarus, Inc. (NASDAQ: SNTS) announced that it submitted a New Drug Application (NDA) for UCERIS (budesonide) Tablets 9 mg for the induction of remission of mild to moderate active ulcerative colitis. UCERIS is being developed in collaboration with Cosmo Technologies Limited, a subsidiary of Cosmo Pharmaceuticals S.p.A. The company had been aiming for some time to file the […]

Daily News Read more